Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib

[1]  A. Esparís-Ogando,et al.  Bortezomib is an efficient agent in plasma cell leukemias , 2005, International journal of cancer.

[2]  D. Esseltine,et al.  A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma , 2004, British journal of haematology.

[3]  Bart Barlogie,et al.  A phase 2 study of bortezomib in relapsed, refractory myeloma. , 2003, The New England journal of medicine.

[4]  S. Jagannath,et al.  CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION , 1998, British journal of haematology.

[5]  E. Brusamolino,et al.  Plasma cell leukemia: A report on 15 patients , 1989, European journal of haematology. Supplementum.

[6]  R. Gale,et al.  Plasma cell leukemia. , 1987, Seminars in hematology.

[7]  R. Kyle,et al.  Plasma cell leukemia. Report on 17 cases. , 1974, Archives of internal medicine.

[8]  F. Leibetseder,et al.  [Plasma cell leukemia]. , 1973, Blut.